Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132626) titled 'Application Research of Standardized Management Pathways for Cancer Pain Based on Hydromorphone Sustained-Release Tablets: A Multicenter Randomized Controlled Trial' on Sept. 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shandong Provincial Hospital
Condition:
Cancer Pain
Intervention:
Oxycodone Hydrochloride Extended-Release Tablet Group:Patients received oral oxycodone hydrochloride extended-release tablets.
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: Oxycodone Hydrochloride Extended-Release Tablet Group:99;Hy...